Provided by Tiger Trade Technology Pte. Ltd.

Enanta Pharmaceuticals

13.16
-0.0700-0.53%
Post-market: 13.160.00000.00%17:40 EDT
Volume:188.00K
Turnover:2.47M
Market Cap:381.88M
PE:-5.06
High:13.31
Open:13.19
Low:13.02
Close:13.23
52wk High:17.15
52wk Low:5.88
Shares:29.02M
Float Shares:20.83M
Volume Ratio:0.87
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6000
EPS(LYR):-3.8381
ROE:-59.00%
ROA:-11.84%
PB:3.28
PE(LYR):-3.43

Loading ...

Top Premarket Decliners

MT Newswires Live
·
Apr 06

Enanta to present preclinical data on oral STAT6 inhibitor EPS-3903 at IMMUNOLOGY2026

Reuters
·
Mar 30

Enanta Pharmaceuticals appeal oral argument set for May 11, 2026; litigation targets Pfizer over Paxlovid patent infringement

Reuters
·
Mar 26

Enanta initiated with a Buy at Rodman & Renshaw

TIPRANKS
·
Mar 26

Enanta Pharmaceuticals to Present at The Citizens Life Sciences Conference

Reuters
·
Mar 03

Enanta Pharmaceuticals: RSV Monoclonal Headwinds Turn Tailwind for Zelicapavir Treatment Opportunity

TIPRANKS
·
Feb 21

Enanta files $150M mixed securities shelf

TIPRANKS
·
Feb 12

Enanta Pharmaceuticals Inc - May Offer up to $150 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Feb 12

Enanta Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 10

Enanta Pharmaceuticals präsentiert präklinische Daten zu EDP-978 auf der AAAAI-Jahrestagung

Reuters
·
Feb 10

Enanta Pharmaceuticals Q1 revenue beats estimates

Reuters
·
Feb 10

Enanta reports Q1 EPS (42c), consensus (88c)

TIPRANKS
·
Feb 10

BRIEF-Enanta Pharmaceuticals Q1 Revenue USD 18.615 Million Vs. IBES Estimate USD 16.1 Million

Reuters
·
Feb 10

Enanta Pharmaceuticals Inc. Q1 net loss narrows to USD 11.9 million

Reuters
·
Feb 10

Enanta Pharmaceuticals Q1 Pretax Profit USD -11.914 Million

THOMSON REUTERS
·
Feb 10

Enanta Pharmaceuticals : Expects Available Cash and Royalties to Fund Operations Into Fiscal 2029

THOMSON REUTERS
·
Feb 10

Enanta Pharmaceuticals Inc: on Track to File an Ind in 2H 2026 for EPS-3903

THOMSON REUTERS
·
Feb 10

Enanta Pharmaceuticals: on Track to File Ind in 1Q 2026 and Report Phase 1 Data in 4Q 2026 for Edp-978

THOMSON REUTERS
·
Feb 10

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal First Quarter Ended December 31, 2025

THOMSON REUTERS
·
Feb 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 09